Spero Therapeutics
SPRO
#10353
Rank
NZ$79.02 M
Marketcap
NZ$1.36
Share price
-10.20%
Change (1 day)
-68.13%
Change (1 year)

EPS for Spero Therapeutics (SPRO)

EPS in 2026 (TTM): NZ$0.23

According to Spero Therapeutics's latest financial reports the company's current EPS (TTM) is NZ$0.26. In 2025 the company made an earnings per share (EPS) of NZ$0.27 an increase over its 2024 EPS that were of NZ-$2.32.

EPS history for Spero Therapeutics from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$0.23-14.34%
2025NZ$0.27-111.81%
2024NZ-$2.32
2022NZ-$3.03
2020NZ-$6.609.39%
2019NZ-$6.0325.48%
2018NZ-$4.81-51.35%
2017NZ-$9.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
IBM
IBM
NZ$21.75 8,400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Thomson Reuters
TRI
NZ$6.58 2,469.83%๐Ÿ‡จ๐Ÿ‡ฆ Canada
Franklin Covey
FC
NZ$0.84 228.57%๐Ÿ‡บ๐Ÿ‡ธ USA